News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 August 27, 2026 Vimseltinib for Patients With Tenosynovial Giant Cell Tumor: A Multicenter, Open-Label, Phase 2 Trial July 13, 2026 IGNITE: A Phase III Study of Tirabrutinib Versus Rituximab and Temozolomide Combination Therapy in Relapsed/Refractory Primary Central Nervous System Lymphoma July 7, 2026 Expert Video Summary: Results of an Exploratory ctDNA Biomarker Analysis in Advanced GIST
August 27, 2026 Vimseltinib for Patients With Tenosynovial Giant Cell Tumor: A Multicenter, Open-Label, Phase 2 Trial
July 13, 2026 IGNITE: A Phase III Study of Tirabrutinib Versus Rituximab and Temozolomide Combination Therapy in Relapsed/Refractory Primary Central Nervous System Lymphoma
July 7, 2026 Expert Video Summary: Results of an Exploratory ctDNA Biomarker Analysis in Advanced GIST
